default author photo

Li Zhang

Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

3

DOWNLOADS

138

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Temporal Pattern of Cardiac Adverse Events Associated with EGFR-TKIs in Lung Cancer Patients: A Pharmacovigilance Analysis

Number of pages: 27 Posted: 19 Jul 2022
Dongchen Sun, Jiaqing Liu, Huaqiang Zhou, Mengting Shi, Gang Chen, Kongjia Luo, Wenfeng Fang, Yunpeng Yang, Yan Huang and Li Zhang
Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Department of Thoracic Surgery, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center and Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center
Downloads 69 (899,324)

Abstract:

Loading...

EGFR-TKI, Cardiac adverse events, Cardiotoxicity, Targeted therapies, Pharmacovigilance analysis

2.

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study

Number of pages: 37 Posted: 24 Jun 2026
Huaqiang Zhou, Qing Zhou, Qisen Guo, Wei Guo, Gongyan Chen, Zhe Liu, Yun Fan, Yan Li, Yuh-Min Chen, Kenza Bouras, Laurence Del Frari, Angela Guo, Isabelle Klauck, Benoît Sansas and Li Zhang
Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Shandong University - Shandong Cancer Hospital, Shanxi Cancer Hospital, Harbin Medical University - Department of Respiratory Medicine, affiliation not provided to SSRN, Chinese Academy of Sciences (CAS) - Key Laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Chongqing University Cancer Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center
Downloads 35

Abstract:

Loading...

encorafenib, binimetinib, China, BRAFV600E, Non-small cell lung cancer

3.

Impact of Smoking Status on the Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors Plus Anti-Vascular Endothelial Growth Factor Antibodies in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Number of pages: 24 Posted: 13 Jul 2022
Jiani Zheng, Zhiqiao Liu, Gang Chen, Yuanyuan Zhao, Yunpeng Yang, Wenfeng Fang and Li Zhang
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center and Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center
Downloads 34 (1,290,922)
Citation 1

Abstract:

Loading...

Epidermal growth factor receptor-tyrosine kinase inhibitors, Anti-vascular endothelial growth factor (VEGF) antibodies, Smoking, lung cancer, Meta-analysis.